Colette 0.25mg Tablet

Composition Cabergoline (0.25mg)
Rx Prescription Required
Pack strip of 4 tablets
Storage Store below 30°C
Chemical Class Ergolines
Action Class Dopamine agonists-Hyperprolactinemia
Habbit Forming No
Manufacturer Cipla Ltd
Manufacturer address Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Colette 0.25mg Tablet should be taken with food,  but take it at the same time to get the most benefit. It should be taken as your doctor’s advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. Swallow the tablets whole with a drink of water. You should take this medicine for as long as it is prescribed for you.

The most common side effects of this medicine include nausea, headache, dizziness, and low blood pressure. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them.  To overcome dizziness, you must avoid driving or rise slowly from sitting or lying position.

Before taking this medicine, tell your doctor if you have ever had high blood pressure after birth, or had heart disease. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Your doctor may check blood pressure regularly while taking this medicine.

Treatment of High levels of prolactin

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Colette 0.25mg Tablet is to be taken with food.

Colette 0.25mg Tablet works by decreasing the release of prolactin, a hormone that stimulates breast milk production. This stops the production of breast milk in case of stillbirth, abortion or miscarriage.

If you miss a dose of Colette 0.25mg Tablet, skip it and continue with your normal schedule. Do not double the dose.

Colette 0.25mg Tablet is used to treat conditions such as infertility or abnormal production of breast milk (galactorrhoea) caused due to excess production of a natural hormone called prolactin.

To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.

Do not take Colette 0.25mg Tablet if you are breastfeeding.

Take it with or after food to avoid side effects such as nausea or indigestion.

Be cautious while driving or doing anything that requires concentration as Colette 0.25mg Tablet can cause dizziness and sleepiness.

Regular monitoring of blood pressure may be advised during treatment with Colette 0.25mg Tablet.

Q. What is Colette 0.25mg Tablet and what is it used for?

Colette 0.25mg Tablet contains Cabergoline, which belongs to a group of medicines that reduces the level of prolactin. It is used to treat medical problems such as galactorrhoea due to abnormally high level of prolactin. It is also used to stops breast milk production (lactation) in case of stillbirth, abortion or miscarriage.

Q. How and in what dose should I take Colette 0.25mg Tablet?

Take this medicine, as per the advice of your doctor. The advised dose and duration depend on your medical condition. It is recommended to take this medicine with food or after food, to reduce the chances of nausea or vomiting.

Q.  What are the possible side effects of using Colette 0.25mg Tablet?

During the first few days of treatment, this medicine may decrease your blood pressure which could make you feel dizzy. So, it is recommended that you change your position slowly when trying to sit, stand or lie down during the initial days of the treatment. Your doctor may suggest you to monitor your blood pressure regularly during these days. The other common side effects are drowsiness, nausea, headache, dizziness, vertigo, stomach pain, indigestion, fatigue, and weakness. If any of these side effects bother you, consult your doctor.

Information not available at the moment. Please check back later.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Vomiting

Vertigo

Headache

Fatigue

Dizziness

Constipation

Nausea

Indigestion

Hot flashes

Drowsiness

Blurred vision

Alcohol:CAUTION

Caution is advised when consuming alcohol with Colette 0.25mg Tablet. Please consult your doctor.

Pregnancy:SAFE IF PRESCRIBED

Colette 0.25mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding:CONSULT YOUR DOCTOR

Colette 0.25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.Colette 0.25mg Tablet is usually not used during breastfeeding because it suppresses lactation.

Driving:UNSAFE

Colette 0.25mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney:SAFE IF PRESCRIBED

Colette 0.25mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Colette 0.25mg Tablet may not be needed in these patients. Please consult your doctor.

Liver:CAUTION

Colette 0.25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Colette 0.25mg Tablet may be needed. Please consult your doctor.

Parker KL, Schimmer BP. Introduction To Endocrinology: The Hypothalamic-Pituitary Axis. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1114-15.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 176-709.

Mayo Clinic. Cabergoline. view

Cabergoline. Sandwich, Kent: Pfizer Limited; 1996 . view

Cabergoiline. New York, New York: Pfizer; 2014. view

Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr . 2004;80:S189-S198. view